- Home
- PSNYW vs ORIC Comparison
PSNYW vs ORIC Comparison
Compare PSNYW & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNYW
- ORIC
- Stock Information
- Founded
- PSNYW 2017
- ORIC 2014
- Country
- PSNYW Sweden
- ORIC United States
- Employees
- PSNYW N/A
- ORIC N/A
- Industry
- PSNYW Auto Manufacturing
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- PSNYW Consumer Discretionary
- ORIC Health Care
- Exchange
- PSNYW Nasdaq
- ORIC Nasdaq
- Market Cap
- PSNYW 352.9M
- ORIC 362.9M
- IPO Year
- PSNYW N/A
- ORIC 2020
- Fundamental
- Price
- PSNYW $0.17
- ORIC $4.77
- Analyst Decision
- PSNYW
- ORIC Strong Buy
- Analyst Count
- PSNYW 0
- ORIC 9
- Target Price
- PSNYW N/A
- ORIC $18.43
- AVG Volume (30 Days)
- PSNYW 79.9K
- ORIC 969.8K
- Earning Date
- PSNYW 03-06-2025
- ORIC 05-05-2025
- Dividend Yield
- PSNYW N/A
- ORIC N/A
- EPS Growth
- PSNYW N/A
- ORIC N/A
- EPS
- PSNYW N/A
- ORIC N/A
- Revenue
- PSNYW $2,046,740,000.00
- ORIC N/A
- Revenue This Year
- PSNYW N/A
- ORIC N/A
- Revenue Next Year
- PSNYW $77.28
- ORIC N/A
- P/E Ratio
- PSNYW N/A
- ORIC N/A
- Revenue Growth
- PSNYW N/A
- ORIC N/A
- 52 Week Low
- PSNYW $0.09
- ORIC $3.90
- 52 Week High
- PSNYW $0.61
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- PSNYW 47.73
- ORIC 37.10
- Support Level
- PSNYW $0.16
- ORIC $3.90
- Resistance Level
- PSNYW $0.18
- ORIC $5.38
- Average True Range (ATR)
- PSNYW 0.02
- ORIC 0.53
- MACD
- PSNYW 0.00
- ORIC 0.06
- Stochastic Oscillator
- PSNYW 72.28
- ORIC 41.97
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.